Skip to main content
. 2017 Nov 24;15(2):1580–1590. doi: 10.3892/ol.2017.7484

Figure 4.

Figure 4.

iNKT+IFN-γ+: iNKT+IL-4+ ratio in HVs and in patients with CLL. CLL, chronic lymphocytic leukemia; iNKT, invariant natural killer T cells; IL, interleukin; IFN, interferon; HV, healthy volunteer.